---
figid: PMC9048097__gr9
pmcid: PMC9048097
image_filename: gr9.jpg
figure_link: /pmc/articles/PMC9048097/figure/f0045/
number: Fig. 9
figure_title: ''
caption: Schematic diagram showing that luteolin modulates the chemoresistance of
  osteosarcoma through inhibiting the PTN-guided ALK//β-catenin/MDR1 signaling pathway
  by upregulating miR-384.
article_title: Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting
  the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384.
citation: Tao Qin, et al. J Bone Oncol. 2022 Jun;34:100429.
year: '2022'

doi: 10.1016/j.jbo.2022.100429
journal_title: Journal of Bone Oncology
journal_nlm_ta: J Bone Oncol
publisher_name: Elsevier

keywords:
- Luteolin
- Osteosarcoma
- Chemoresistance
- PTN
- PTN, pleiotrophin
- MDR, multidrug resistance
- OS, osteosarcoma
- P-gp, P-glycoprotein

---
